Liothyronine Sodium Tablets, USP 25 mcg ,100-count bottles, Rx Only, Distributed by Perrigo Minneapolis, MN 55427, NDC 0574-0222-01
Published December 6, 2017 · Recall initiated: November 9, 2017
Summary
FDA records drug Class II recall D-0098-2018, published December 6, 2017 and initiated November 9, 2017. Recalling firm: Mayne Pharma Inc; Status: Terminated; Reported quantity: 11,364 bottles; Lot: Lot: #:16F649, Exp: May 2018. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Dissolution Specifications.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Mayne Pharma Inc
- Distributor
- Nationwide within USA
- Lot
- Lot: #:16F649, Exp: May 2018
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAClonidine Transdermal System, USP 0.3 mg/day, 4 Patches (NDC 51862-455-01) per Carton (51862-455-04), Rx only,June 29, 2022
- FDALexette (halobetasol propionate) Topical Foam, 0.05% 50 g canisters, Rx ONLY, Distributed by: Mayne PharmaJanuary 26, 2022
- FDACarbidopa and Levodopa Tablets, USP 25 mg/250mg, 100 ct bottle, Rx Only, Mayne Pharma, Greenville, NC 27834.March 18, 2020
- FDAOxycodone and Acetaminophen Tablets, USP, 5 mg*/325 mg, 100-count bottle, Rx Only, Manufactured by: MayneSeptember 5, 2018
- FDADuloxetine Delayed-Release Capsules USP, 30 mg, 30-count bottles, Rx Only, Manufactured for: LupinDecember 6, 2017
- FDALevetiracetam Oral Solution, USP, 100 mg/mL, packaged in a 16 fl oz (473 mL) bottle, Rx only, ManufacturedDecember 6, 2017
Questions about this recall
Was Liothyronine Sodium Tablets, USP 25 mcg ,100-count bottles, Rx Only, Distributed by Perrigo Minneapolis, MN 55427, NDC 0574-0222-01 recalled?
Yes. FDA published recall D-0098-2018 on December 6, 2017. Reported hazard: Failed Dissolution Specifications.
What should I do if I have this product?
Voluntary: Firm initiated · Letter